MedPath

Clinical Application of Nutrition Support Package Before Hepatectomy

Not Applicable
Conditions
Hepatectomy
Liver Neoplasms
Nutrition Therapy
Interventions
Dietary Supplement: 300 calories or 500 calories nutrient rich in branched chain amino acids and dietary fiber
Behavioral: Dietary mission
Registration Number
NCT04218253
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Brief Summary

Objective:To confirm the effect of preoperative oral nutrition therapy on patients with malnourished before liver cancer resection.

Study design:Prospective, randomized, controlled clinical study. Primary end point: incidence of all complications 30 days after surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
    1. Clinical diagnosis of primary liver cancer (including hepatocellular carcinoma, bile duct carcinoma, and mixed cell carcinoma)
    1. No contraindications for surgery
    1. Eastern Cooperative Oncology Group (ECOG) score of preoperative physical state <2 points
    1. Preoperative liver function score Child-Pugh ≤ 6 points: total bilirubin ≤ 3.0 mg / dl, albumin ≥ 28 g / L, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) ≤ 5 times the upper limit of normal
    1. Voluntarily enter the study and sign the informed consent form, and communicate well with the researcher
Exclusion Criteria
    1. Patients who took fish oil supplements within 3 weeks before the study began
    1. Patients with severe nutritional risk: serious nutritional risk should be considered when combining any of the following conditions: weight loss > 10% within 6 months; digital pain score (NRS) score > 5 points; BMI <18.5 kg/m2 (all patients with severe nutritional risk undergo individualized supportive care);
    1. Patients with malignant tumors in other parts
    1. Patients who are pregnant or lactating
    1. Patients with mental and neurological disorders who cannot cooperate with medical staff
    1. Patients with severe diabetes or poor glycemic control
    1. Patients cannot tolerate nutritional preparations
    1. Other circumstances that the researcher considers inappropriate to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
nutritional intervention300 calories or 500 calories nutrient rich in branched chain amino acids and dietary fiber300 or 500 calories nutritional support before operation according to the level of malnutrition
nutritional interventionDietary mission300 or 500 calories nutritional support before operation according to the level of malnutrition
control groupDietary missionDietary education was conducted according to preoperative nutritional requirements
Primary Outcome Measures
NameTimeMethod
Incidence of complications at 30 days after surgeryup to 30 days after surgery

Postoperative complications were defined by Clavien-Dindo. Grade 1: Any deviation from the normal postoperative course without the need for pharmacologic treatment or surgical, endoscopic, and radiologic interventions. Allowed therapeutic regimens are drugs as antiemetics, antipyretics, analgetics, and diuretics, and electrolytes and physiotherapy. This grade also includes wound infections opened at the bedside.

Grade 2: Requiring pharmacologic treatment with drugs other than such allowed for grade I complications. Blood transfusions and total parenteral nutrition are also included.

Grade 3: Requiring surgical, endoscopic, or radiologic intervention 3a: Intervention not under general anesthesia 3b: Intervention under general anesthesia Grade 4:Life-threatening complication (including CNS complications) requiring IC/ICU management.

4a: Single organ dysfunction (including dialysis) 4b: Multiple organ dysfunction Grade 5: Death as a result of complications

Secondary Outcome Measures
NameTimeMethod
Postoperative hospital stayup to 90 days after surgery

from the date of the operation to the date of discharge

Trial Locations

Locations (1)

Tianjin Medical University cancer Instituteand Hospital

🇨🇳

Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath